These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Is the natriuretic effect of atrial natriuretic factor in conscious rats mediated by renal vasodilatation?
    Author: Sonnenburg C, Muir AC, Criscione L, Kraetz J, Hofbauer KG.
    Journal: J Hypertens Suppl; 1985 Dec; 3(3):S303-5. PubMed ID: 2856723.
    Abstract:
    Atrial natriuretic factors (ANF) have both vasorelaxant and natriuretic properties. It has been suggested that their effects on sodium excretion depend on renal vasodilatation. We studied the haemodynamic (ultrasound Doppler flow probes) effects of synthetic atriopeptin II at natriuretic doses in conscious rats. Intravenous injections of atriopeptin II induced a marked, dose-dependent increase in sodium excretion. This was accompanied by a slight reduction in blood pressure (BP) and a transient decrease in renal, mesenteric and aortic blood flow. In contrast, a selective renal vasodilator, CGP 22,979, induced a moderate increase in sodium excretion concomitantly with a rise in renal blood flow. Blood pressure and the other regional flows remained unchanged. These findings suggest that the natriuretic effect of CGP 22,979 is closely related to an increased renal blood flow. Conversely, the natriuresis induced by atriopeptin II is not accompanied by selective renal vasodilatation and appears to be due either to a tubular action or to changes in intrarenal haemodynamics.
    [Abstract] [Full Text] [Related] [New Search]